Cite
HARVARD Citation
Lajara, R. et al. (2023). IGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real‐world study. Diabetes, obesity & metabolism. 25 (5), pp. 1249-1260. [Online].